Publs. oficiales Takeda Pharmaceutical Company Limited Sapporo S.E.

Acciones

Mercado cerrado - Sapporo S.E. Otros sitios de cotización 01:53:52 11/03/2024			Varia. Cinco días.	Varia. 1 de enero.
4.300 ^JPY	-1,15 %		-.--%	+8,18 %

18/06	Takeda Pharmaceutical afirma que los resultados de un ensayo de fase 3 respaldan el uso de Hyqvia como tratamiento de mantenimiento de la polineuropatía desmielinizante crónica	MT
18/06	Takeda anuncia los datos del ensayo clínico de fase 3 ADVANCE-CIDP 3 de HYQVIA en pacientes con polineuropatía desmielinizante inflamatoria crónica en la Reunión Anual de PNS	CI

Slide show results	09/05	CO
Annual results	09/05	CO
4th quarter report	09/05	CO
Slide show Q3	01/02	CO
3rd quarter results	01/02	CO
3rd quarter report	01/02	CO
Changes in management and corporate officers	18/01	CO
Slide show half-year results	26/10/23	CO
1st-half-year results	26/10/23	CO
Slide show Q1	27/07/23	CO
1st quarter results	27/07/23	CO
Minutes of the general assembly	28/06/23	CO
Mixed general shareholder meeting	06/06/23	CO
Slide show results	11/05/23	CO
Annual results	11/05/23	CO
Integrated report	31/03/23	CO
Annual Report	31/03/23	CO
Slide show Q3	02/02/23	CO
3rd quarter results	02/02/23	CO
3rd quarter report	02/02/23	CO
Slide show half-year results	27/10/22	CO
Half-year report	27/10/22	CO
1st quarter report	28/07/22	CO
Slide show Q1	28/07/22	CO
1st quarter results	28/07/22	CO